Identification of potential biomarkers for papillary thyroid carcinoma by comprehensive bioinformatics analysis
- 12 January 2023
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 478 (9) , 2111-2123
Abstract
To perform bioinformatics analysis on the papillary thyroid carcinoma (PTC) gene chip dataset to explore new biological markers for PTC. The gene expression profiles of GSE3467 and GSE6004 chip data were collected by GEO2R, and the differentially expressed genes (DEGs) were selected for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. Protein–protein interaction (PPI) relationship analysis was achieved using STRING, and the hub genes were obtained using the Cytoscape software. GEPIA was used to validate the expressions of the hub genes in the normal and tumor tissues and to conduct survival analyses. Pertinent genetic pathology results were fetched using the HPA database. Finally, the key genes were clinically verified by reverse transcription-polymerase chain reaction. 97 genes were jointly up-regulated and 107 genes were jointly down-regulated in GSE3467 and GSE6004. GO function enrichment analysis revealed that the DEGs were involved in the regulation of calcium ion transport into cytosol, integrin binding, and cell adhesion molecule binding. KEGG pathway enrichment analysis indicated that the DEGs were chiefly associated with thyroid cancer and non-small cell lung cancer. According to the PPI network, 30 key target genes were identified. Only the expressions of ANK2, TLE1, and TCF4 matched between the normal and tumor tissues, and were associated with disease prognosis. When compared with the normal thyroid tissues, the protein and mRNA expressions of ANK2, TLE1, and TCF4 were down-regulated in PTC. Significant differences exist in overall gene expression between the thyroid tissues of patients with PTC and those of healthy people. Furthermore, the differential genes ANK2, TLE1, and TCF4 are expected to be reliable molecular markers for the mechanism study and diagnosis of PTC.Keywords
Funding Information
- Natural Science Foundation of Hubei Province (2016CFB673)
This publication has 36 references indexed in Scilit:
- Transducing-Like Enhancer of Split 1: A Potential Immunohistochemical Marker for Glomus TumorThe American Journal of Dermatopathology, 2017
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analysesNucleic Acids Research, 2017
- Identification of key pathways and genes in colorectal cancer using bioinformatics analysisMedical Oncology, 2016
- Prognostic and Clinicopathological Significance of Transducer-Like Enhancer of Split 1 Expression in Gastric CancerJournal of Gastric Cancer, 2016
- Novel prognostic genes of diffuse large B-cell lymphoma revealed by survival analysis of gene expression dataOncoTargets and Therapy, 2015
- Big data mining yields novel insights on cancerNature Genetics, 2015
- High expression of transcription factor 4 (TCF4) is an independent adverse prognostic factor in acute myeloid leukemia that could guide treatment decisionsHaematologica, 2014
- Inhibition of Ankyrin-B Expression Reduces Growth and Invasion of Human Pancreatic Ductal AdenocarcinomaPancreatology, 2010
- Copy Number and Gene Expression Alterations in Radiation-Induced Papillary Thyroid Carcinoma from Chernobyl Pediatric PatientsThyroid®, 2010
- The effect of GeneChip gene definitions on the microarray study of cancersBioEssays, 2006